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the study was to evaluate the predictive value of 
LA and RA size and function on AF recurrence 
after RFCA. To minimize the impact of the left 
ventricle (LV) on atrial deformation, only pa‑
tients with LV ejection fraction (LVEF) of 50% 
or more were included in the analysis.
Methods This single‑center prospective study 
included 41 patients with paroxysmal or per‑
sistent nonvalvular AF who underwent ini‑
tial RFCA between January 2014 and Decem‑
ber 2017. Only patients in sinus rhythm and 
with LVEF of 50% or more were eligible for en‑
rollment. Follow‑up visits with 12‑lead electro‑
cardiogram (ECG) and 24‑hour Holter recording 
were scheduled at 3 and at least 6 months after 
RFCA at an outpatient arrhythmia clinic. Each 
outpatient who developed symptoms suggestive 
of AF was advised to undergo immediate ECG 
recording. The RFCA procedure was considered 
successful if during the follow‑up, after a blank‑
ing period of 3 months, there was no recurrence 
of AF lasting more than 30 seconds, as detect‑
ed on serial ECG or 24‑hour Holter monitoring.
A detailed description of the RFCA procedure 
and echocardiographic study with strain mea‑
surements can be found in the supplementa‑
ry material.
Statistical analysis Variables were compared 
with the t test for independent values, Mann–
Whitney test, χ2 test with Yates correction, or 
Introduction The rate of atrial fibrillation 
(AF) recurrence after a single radiofrequency 
catheter ablation (RFCA) procedure is report‑
ed to be as high as 30% to 50%. Multiple fac‑
tors have been identified as related with AF re‑
lapse after RFCA; however, their predictive val‑
ue is rather small.1 Therefore, new predictors of 
procedural outcome are needed for better iden‑
tification of patients who will benefit the most 
from RFCA.
Left atrial (LA) structural and functional re‑
modeling has been recognized as an important 
risk factor for AF recurrence. On the other hand, 
AF is a biatrial disease and the enlargement of 
the right atrium (RA) contributes to AF relapse 
to a similar degree as LA remodeling.2 Although 
RA fibrosis and remodeling have been report‑
ed in patients with paroxysmal AF,3 and struc‑
tural biatrial remodeling has been shown to be 
significantly correlated with this arrhythmia,4 
the impact of RA and both LA and RA function 
on AF recurrence after RFCA has not been in‑
vestigated. Subtle cardiac dysfunctions can be 
recognized on 2‑dimensional speckle tracking 
echocardiography (2D‑STE), even when they 
are not yet visible on conventional echocardio‑
graphic analysis. Hence, application of 2D‑STE 
before RFCA can improve identification of myo‑
cardial alterations linked to AF recurrence. We 
hypothesized that the extent of remodeling of 
both atria, and not the LA alone, would be as‑
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Group without AF 
recurrence after PVI 
(n = 26)




Age, y, mean (SD) 55 (11) 54 (11) 55 (11) 0.96
Male sex, n (%) 25 (61) 18 (69) 7 (47) 0.27
BMI, kg/m², mean (SD) 29 (4) 29 (4) 29 (4) 0.55
Persistent AF, n (%) 7 (17) 2 (8) 5 (33) 0.09
History of AF, y, median (IQR) 3 (2–7) 3 (2–7) 5 (3–8) 0.22c
Documented AFl, n (%) 6 (15) 3 (12) 3 (20) 0.78
Hypertension, n (%) 21 (51) 13 (50) 8 (53) 0.91
Hypercholesterolemia, n (%) 11 (27) 5 (19) 6 (40) 0.28
Obesity (BMI >30 kg/m²), n (%) 15 (37) 10 (38) 5 (33) 0.99
Type 2 diabetes, n (%) 2 (5) 2 (8) None 0.73
Stable CAD, n (%) 2 (5) 2 (8) None 0.73
CTI ablation, n (%) 1 (2) 1 (4) None 0.78
AVRT/AVNRT ablation, n (%) 2 (5) 2 (8) None 0.73
CHA₂DS₂-VASC score, n (%)
Score 0 10 (24) 6 (23) 4 (27) 0.76b
Score 1 15 (37) 11 (42) 4 (27)
Score 2 10 (24) 6 (23) 4 (27)
Score 3 6 (15) 3 (12) 3 (20)
Pharmacotherapy, n (%)
Amiodarone 6 (15) 3 (12) 3 (20) 0.78
Sotalol 8 (20) 8 (31) None <0.05
Class I C antiarrhythmic drugs 15 (37) 7 (27) 8 (53) 0.18
No antiarrhythmic drugs 12 (29) 8 (31) 4 (27) 0.94
β‑Blockers 18 (44) 9 (35) 9 (60) 0.21
Calcium antagonists 8 (20) 7 (27) 1 (7) 0.16
ACEIs/ARBs 16 (39) 9 (35) 7 (47) 0.67
Statins 18 (44) 12 (46) 6 (40) 0.96
Aldosterone antagonists 5 (5) 1 (4) 4 (27) 0.10
Echocardiographic results
Heart rate, bpm, mean (SD) 61 (10) 63 (12) 59 (6) 0.70
IVS, mm, mean (SD) 11 (2) 11 (1) 10 (2) 0.73
PW, mm, median (IQR) 10 (9–11) 10 (9–10) 10 (9–11) 0.24c
LV end‑diastolic volume, ml, mean (SD) 97 (21) 99 (23) 94 (18) 0.50
LV end‑systolic volume, ml, median (IQR) 36 (30–45) 37 (31–45) 34 (30–44) 0.87c
LVEF, %, mean (SD) 62 (6) 63 (5) 59 (7) 0.10
LV‑GLS, %, mean (SD) –20 (3) –20 (2) –19 (4) 0.30
RV end‑diastolic area, cm², median (IQR) 19 (17–22) 19 (18–22) 18 (17–19) 0.12c
s’RV, cm/s, mean (SD) 1.3 (0.4) 1.4 (0.3) 1.2 (0.3) 0.07
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the 2 groups apart from sotalol use, which was 
more frequent in the group with AF recurrence.
The mean LV and right ventricular size and 
function were normal (TABLE 1). Both the LA and 
RA were mildly enlarged with slightly reduced 
function (mean [SD] LA strain, 25% [6%]; mean 
[SD] RA strain, 31% [10%]).
In the univariate analysis, LA minimal and 
maximal volumes, LA emptying fraction (LAEF), 
LA strain, and biatrial strain were predictors 
of AF recurrence (Supplementary material, Ta-
ble S1, Figure S1).
In the ROC analysis, the respective cut‑off val‑
ues for sinus rhythm maintenance after RFCA 
were LA minimal volume of less than 35 ml 
(sensitivity, 87%; specificity, 46%; area under 
the curve [AUC], 0.69), LA maximal volume of 
less than 69 ml (sensitivity, 62%; specificity, 
40%; AUC, 0.51), LAEF of more than 41% (sen‑
sitivity, 81%; specificity, 53%; AUC, 0.73), LA 
strain of more than 22% (sensitivity, 89%; spec‑
ificity, 60%; AUC, 0.76), and biatrial strain  of 
more than 24.75% (sensitivity, 74%; specificity, 
80%; AUC, 0.80).
In multivariate analysis, biatrial strain was 
the main independent predictor of AF recurrence 
after RFCA (odds ratio, 1.21; 95% CI, 1.05–1.41; 
P = 0.011) (Supplementary material, Table S1).
Fisher exact test, as appropriate. Receiver op‑
erating characteristic (ROC) curves were con‑
structed to calculate adjusted cut‑off values 
of variables for predicting AF recurrence after 
RFCA. The logistic regression analysis was ap‑
plied to identify variables that independent‑
ly predicted AF relapse. The variables with uni‑
variate P value of 0.1 or less and no colinearity 
between each other were included in the multi‑
variate logistic regression model. For that rea‑
son only 1 parameter determining the LA func‑
tion or size was taken into consideration in mul‑
tivariate analysis. A P value of less than 0.05 was 
considered statistically significant. The STATA 
software (version 15.1, StataCorp LLC, College 
Station, Texas, United States) was used for sta‑
tistical calculations.
Results and discussion Clinical and prepro‑
cedural echocardiographic characteristics of 
the study population are listed in TABLE 1. Bidirec‑
tional electrical pulmonary vein isolation was 
completed in all patients. During a mean (SD) 
follow‑up of 13 (7) months after the RFCA pro‑
cedure, 15 patients (37%) presented with recur‑
rence of AF, while 26 (63%) were free from AF. 
There were no significant differences in clinical 





Group without AF 
recurrence after PVI
(n = 26)




RV strain, %, mean (SD) –21 (5) –21 (5) –20 (5) 0.32
LA diameter, mm, mean (SD) 40 (5) 39 (5) 40 (5) 0.50
Minimum LA volume, ml, mean (SD) 43 (18) 36 (11) 47 (15) <0.01
Maximum LA volume, ml, mean (SD) 80 (23) 72 (16) 86 (21) 0.03
LAVI, ml/m², mean (SD) 40 (12) 37 (10) 44 (12) 0.05
LAEF, %, mean (SD) 47 (11) 50 (10) 42 (10) 0.01
LA strain, %, mean (SD) 25 (6) 27 (5) 21 (6) <0.01
RAVI, ml/m², median (IQR) 27 (24–30) 26 (24–32) 27 (24–29) 0.90c
RA strain, %, mean (SD) 31 (10) 33 (11) 29 (10) 0.23
Biatrial strain, %, mean (SD) 22 (8) 28 (6) 21 (5) <0.001
E, m/s, mean (SD) 0.7 (0.2) 0.7 (0.1) 0.8 (0.3) 0.09
E/e’, mean (SD) 8 (3) 7 (3) 8 (3) 0.40
a Group with vs without AF recurrence after PVI; P values were calculated with the χ2 test with Yates correction, t test for independent values; Fisher Exact test (b) or 
Mann–Whitney test (c) where appropriate. A P value of less than 0.05 was considered significant.
CHA2DS2‑VASc score: congestive heart failure, hypertension, age >75 years, diabetes mellitus, history of stroke or thromboembolism, vascular disease, age 65 to 74 years, 
female sex
Abbreviations: ACEI, angiotensin‑converting enzyme inhibitor; AF, atrial fibrillation; AFl, atrial flutter; ARB, angiotensin II receptor blocker; AVNRT, atrioventricular nodal 
reentrant tachycardia; AVRT, atrioventricular reentrant tachycardia; BMI, body mass index; CAD, coronary artery disease; CTI, cavo‑tricuspid isthmus; E, early transmitral 
flow velocity by pulsed‑wave Doppler; e’, early diastolic mitral annulus velocity by spectral tissue Doppler; IQR, interquartile range; IVS, interventricular septum; LA, left 
atrial; LAEF, LA emptying fraction; LAVI, LA volume index; LV, left ventricular; LVEF, LV ejection fraction; LV‑GLS, LV global longitudinal peak strain; PVI, pulmonary vein 
isolation; PW, posterior wall; RA, right atrium; RAVI, RA volume index; RV, right ventricular; s’RV, peak systolic velocity of tricuspid annulus by spectral tissue Doppler
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explanations. Yasuda et al8 reported that LA 
strain measured on the LA lateral wall by 2D‑STE 
might be the most useful parameter for predict‑
ing successful AF ablation, as it represents pure 
LA contractile function. Biatrial strain, which 
combines lateral walls of both atria, can be more 
sensitive to atrial wall remodeling than LA strain 
itself. In addition, we believe that evaluation of 
atrial free wall deformation can lead to a more 
precise assessment of true atrial function, as it 
allows to avoid artifactual dropout of the atri‑
al septum in the 4‑chamber view. Moreover, in 
accordance with the results of Akutsu et al,2 we 
may suspect that combined LA and RA dysfunc‑
tion may better reflect a more remarkable over‑
all functional remodeling than individual atrial 
remodeling alone.
The limitation of our study is the possibility 
of overlooking silent AF episodes after RFCA, 
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Our study indicates that in patients with an 
LVEF of more than 50% undergoing the first 
RFCA for AF, larger LA volumes and worse atrial 
function (LAEF, LA strain, biatrial strain) iden‑
tified the group at risk of AF relapse. We found 
that preprocedural biatrial strain was an inde‑
pendent predictor of arrhythmia elimination 
and the value of more than 24.75% best identi‑
fied patients who maintained the sinus rhythm 
after RFCA (supplementary material, Figure S1).
Recently, 2D‑STE has become widely accept‑
ed as an innovative and valuable method of sub‑
tle cardiac dysfunction evaluation. Atrial res‑
ervoir function, determined by LA strain, not 
only reflects the atrial wall distensibility, but is 
also related to chamber stiffness and fibrosis.5 
So far, LA strain measured by 2D‑STE showed 
higher predictive value for RFCA efficacy than 
the LA size or type of AF.6,7 We also found that 
LA strain allows the prediction of arrhythmia 
recurrence after RFCA with adequate sensitiv‑
ity and specificity.
To the best of our knowledge, this is the first 
study that determines the impact of both LA 
and RA function assessed by biatrial strain us‑
ing 2D‑STE on AF elimination after RFCA. This 
atrial strain analysis reflects biatrial reservoir 
function. There is evidence supporting the re‑
lationship between LA and RA remodeling due 
to AF as it results in biatrial enlargement, and 
structural changes in both atria are significant‑
ly correlated.4 Stiles et al3 reported on the pres‑
ence of biatrial electroanatomical abnormalities 
(atrial enlargement, conduction abnormalities, 
and sinus node dysfunction) even in patients 
with paroxysmal lone AF who remained in si‑
nus rhythm and were studied remote from ar‑
rhythmia. Akutsu et al2 analyzed patients with 
paroxysmal AF using a multidetector computed 
tomography and showed that apart from the LA 
structural remodeling, the RA remodeling de‑
fined as RA enlargement was equally associat‑
ed with the outcome of RFCA. Moreover, they 
indicated that the assessment of combined atri‑
al volumes had the highest diagnostic accuracy. 
The present study demonstrated that biatrial 
strain, representing LA and RA functional re‑
modeling, is an important parameter predicting 
arrhythmia recurrence after RFCA. However, we 
found that LA strain was superior to RA strain 
for predicting AF recurrence. Our results indi‑
cate that RA functional changes contribute to 
AF‑related atrial remodeling to a lesser extent. 
We think that the determinant of RA remodel‑
ing in our study was AF itself as we excluded all 
factors which might contribute to RA remodel‑
ing, such as LV systolic dysfunction, myocardi‑
al disease involving the RV, lung disease, or pul‑
monary hypertension.
In our study, biatrial strain turned out to 
be the best predictor of AF recurrence after 
RFCA, and this finding may have a few possible 
